Apontis Pharma AG (APPH.DE)

EUR 10.05

(0.0%)

Total Debt Summary of Apontis Pharma AG

  • Apontis Pharma AG's latest annual total debt in 2023 was 6 Million EUR , down 0.0% from previous year.
  • Apontis Pharma AG's latest quarterly total debt in 2024 Q2 was - EUR , down -100.0% from previous quarter.
  • Apontis Pharma AG reported annual total debt of - EUR in 2022, down 0.0% from previous year.
  • Apontis Pharma AG reported annual total debt of - EUR in 2021, down 0.0% from previous year.
  • Apontis Pharma AG reported quarterly total debt of 6 Million EUR for 2023 Q4, down 0.0% from previous quarter.
  • Apontis Pharma AG reported quarterly total debt of 6 Million EUR for 2023 FY, down 0.0% from previous quarter.

Annual Total Debt Chart of Apontis Pharma AG (2023 - 2018)

Historical Annual Total Debt of Apontis Pharma AG (2023 - 2018)

Year Total Debt Total Debt Growth
2023 6 Million EUR 0.0%
2022 - EUR 0.0%
2021 - EUR 0.0%
2020 - EUR 0.0%
2019 - EUR 0.0%
2018 - EUR 0.0%

Peer Total Debt Comparison of Apontis Pharma AG

Name Total Debt Total Debt Difference
MPH Health Care AG 13.05 Million EUR 54.039%
Dermapharm Holding SE 1.08 Billion EUR 99.445%
Evotec SE 626.19 Million EUR 99.042%
MERCK Kommanditgesellschaft auf Aktien 9.94 Billion EUR 99.94%
PharmaSGP Holding SE 73.97 Million EUR 91.889%
SynBiotic SE 3.68 Million EUR -63.032%